Trending...
- Drug Pricing Bill Caps Years of AHF Advocacy
- Is Will Smith's Apology Good Enough For Be Kind To HumanKind Week?
- Juniper Networks Chosen by Jazz to Build Fully-Automated Data Center Infrastructure to Support Data, Music and Video Services
LAVAL, QC, May 11, 2022 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that the Company will participate in several upcoming investor conferences.
Tom Vadaketh, executive vice president and chief financial officer; William Woodfield, senior vice president and treasurer; and Christina Cheng, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the 7th Annual Goldman Sachs Leveraged Finance and Credit Conference in Long Beach, Calif. on May 12, 2022 at 9:05 a.m. PT and at the Barclays High Yield Bond & Syndicated Loan Conference in Austin, Texas on May 24, 2022 at 11:00 a.m. CT.
A live webcast and audio archive of the conferences will be available on the Investor Relations page of the Bausch Health Companies Inc. website at: https://ir.bauschhealth.com/events-and-presentations/2022.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals and eye health, through our 90% ownership of Bausch + Lomb Corporation. With our leading durable brands, we are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.
More on The Californer
SOURCE Bausch Health Companies Inc.
Tom Vadaketh, executive vice president and chief financial officer; William Woodfield, senior vice president and treasurer; and Christina Cheng, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the 7th Annual Goldman Sachs Leveraged Finance and Credit Conference in Long Beach, Calif. on May 12, 2022 at 9:05 a.m. PT and at the Barclays High Yield Bond & Syndicated Loan Conference in Austin, Texas on May 24, 2022 at 11:00 a.m. CT.
A live webcast and audio archive of the conferences will be available on the Investor Relations page of the Bausch Health Companies Inc. website at: https://ir.bauschhealth.com/events-and-presentations/2022.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals and eye health, through our 90% ownership of Bausch + Lomb Corporation. With our leading durable brands, we are delivering on our commitments as we build an innovative company dedicated to advancing global health. For more information, visit www.bauschhealth.com and connect with us on Twitter and LinkedIn.
More on The Californer
- Cymbiotika Announces Partnership with Medical Advisor Dr. Pejman Taghavi
- ArborWorks LLC Announces the Promotion of Mr. Clint Stephens to Vice President of Operations, Southeastern Region
- What They're Saying: State and Local Leaders Across California Applaud Selection of Antonio Villaraigosa as Infrastructure Advisor
- Agent Timothy Braue Awarded Prestigious "Premier Luxury Marketing Consultant" Certification
- INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Centessa Pharmaceuticals plc with Losses of $100,000 to Contact the Firm
Investor Contact: | Media Contact: |
Christina Cheng | Lainie Keller |
[email protected] | [email protected] |
(514) 856-3855 | (908) 927-1198 |
(877) 281-6642 (toll free) | |
SOURCE Bausch Health Companies Inc.
Filed Under: Business
0 Comments
Latest on The Californer
- San Jose: Notice of CEQA Posting: Eterna Tower Mixed-Use Development Project Addendum
- Governor Newsom Announces Water Strategy For a Hotter, Drier California
- Michael Bay Partners With Jadu to Create AR Avatars
- Certified Access Specialists (CASp) Protect Businesses From ADA Lawsuits
- Larry Elder: An Exclusive Interview
- Governor Newsom Names Antonio Villaraigosa Infrastructure Advisor to Leverage Federal Dollars in Building California Infrastructure for the Next Century
- San Jose: PUBLIC REVIEW DRAFT EIR PDC18-036 BERRYESSA ROAD MIXED USE DEVELOPMENT (SCH#2021070467)
- 4th Annual Southeast Ventura County YMCA Gala
- Hoy to Keep Your Life Productive by Ismail Sirdah
- The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Tuya Inc. (TUYA) Investors
- How to Choose the Best Bamboo Cheese Board for Your Kitchen
- You Are Still the One That Pays for the Leads
- KP Performance Antennas Launches New Series of 5G, Low-PIM, In-Building DAS Antennas
- SentinelOne Integrates with Proofpoint for Enhanced Ransomware Protection
- McGruff the Crime Dog® Stars in 3D Ad to Stop Dangerous Fake Products
- Calpine Containers, Inc. Appoints Packaging and Distribution Executive Sean Gallagher as Chief Executive Officer
- Addmotor Upgrades M-340 Electric Trike to EB 2.0 Electronic System to Enhance Riding Experience
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in LifeStance Health Group, Inc. with Losses of $100,000 to Contact the Firm
- California Officially Launches Nation's Largest College Savings Program for Millions of Students and All Newborns